Malin investee company Poseida Therapeutics files for potential US IPO
US clinical-stage biotechnology company is eyeing a listing on the Nasdaq Global Select Market
Malin chief executive to step down after just one year in the role
Former Ardagh CEO Ian Curley to become executive chairman on an interim basis
Malin investors urged to reject executive pay deal
Series of investments in life science companies have been badly received by the market
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices